Hillsdale Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,490
| Closed | -$1.81M | – | 640 |
|
|
2025
Q2 | $1.81M | Buy |
+6,490
| New | +$1.84M | 0.07% | 286 |
|
|
2024
Q3 | – | Sell |
-60
| Closed | -$18.7K | – | 593 |
|
|
2024
Q2 | $18.7K | Sell |
60
-1,340
| -96% | -$394K | ﹤0.01% | 462 |
|
|
2024
Q1 | $398K | Buy |
1,400
+430
| +44% | +$126K | 0.03% | 343 |
|
|
2023
Q4 | $279K | Buy |
970
+320
| +49% | +$87.2K | 0.02% | 344 |
|
|
2023
Q3 | $175K | Buy |
650
+256
| +65% | +$63.9K | 0.02% | 354 |
|
|
2023
Q2 | $87.5K | Hold |
394
| – | – | 0.01% | 380 |
|
|
2023
Q1 | $95.3K | Sell |
394
-1,545
| -80% | -$379K | 0.01% | 463 |
|
|
2022
Q4 | $509K | Sell |
1,939
-675
| -26% | -$181K | 0.04% | 334 |
|
|
2022
Q3 | $590K | Buy |
2,614
+2,206
| +541% | +$535K | 0.05% | 276 |
|
|
2022
Q2 | $99K | Buy |
408
+83
| +26% | +$20.3K | 0.01% | 427 |
|
|
2022
Q1 | $79K | Buy |
325
+90
| +38% | +$20.7K | 0.01% | 452 |
|
|
2021
Q4 | $53K | Hold |
235
| – | – | ﹤0.01% | 489 |
|
|
2021
Q3 | $50K | Hold |
235
| – | – | ﹤0.01% | 481 |
|
|
2021
Q2 | $57K | Hold |
235
| – | – | ﹤0.01% | 451 |
|
|
2021
Q1 | $58K | Sell |
235
-225
| -49% | -$53.7K | ﹤0.01% | 442 |
|
|
2020
Q4 | $106K | Sell |
460
-1,760
| -79% | -$406K | 0.01% | 407 |
|
|
2020
Q3 | $564K | Sell |
2,220
-670
| -23% | -$166K | 0.06% | 295 |
|
|
2020
Q2 | $681K | Sell |
2,890
-370
| -11% | -$84.4K | 0.06% | 270 |
|
|
2020
Q1 | $661K | Sell |
3,260
-10
| -0.3% | -$2.18K | 0.08% | 227 |
|
|
2019
Q4 | $788K | Hold |
3,270
| – | – | 0.07% | 269 |
|
|
2019
Q3 | $633K | Sell |
3,270
-40
| -1% | -$7.68K | 0.06% | 290 |
|
|
2019
Q2 | $609K | Buy |
3,310
+280
| +9% | +$50.1K | 0.06% | 292 |
|
|
2019
Q1 | $575K | Buy |
3,030
+700
| +30% | +$134K | 0.05% | 257 |
|
|
2018
Q4 | $453K | Hold |
2,330
| – | – | 0.05% | 265 |
|
|
2018
Q3 | $483K | Hold |
2,330
| – | – | 0.06% | 182 |
|
|
2018
Q2 | $430K | Sell |
2,330
-10
| -0.4% | -$1.77K | 0.05% | 215 |
|
|
2018
Q1 | $399K | Hold |
2,340
| – | – | 0.06% | 214 |
|
|
2017
Q4 | $407K | Buy |
2,340
+400
| +21% | +$70.8K | 0.07% | 237 |
|
|
2017
Q3 | $361K | Hold |
1,940
| – | – | 0.06% | 247 |
|
|
2017
Q2 | $334K | Buy |
1,940
+1,880
| +3,133% | +$306K | 0.07% | 226 |
|
|
2017
Q1 | $10K | Sell |
60
-1,500
| -96% | -$249K | ﹤0.01% | 343 |
|
|
2016
Q4 | $228K | Hold |
1,560
| – | – | 0.05% | 272 |
|
|
2016
Q3 | $260K | Sell |
1,560
-400
| -20% | -$67.6K | 0.07% | 280 |
|
|
2016
Q2 | $298K | Sell |
1,960
-300
| -13% | -$46.6K | 0.09% | 272 |
|
|
2016
Q1 | $339K | Buy |
+2,260
| New | +$336K | 0.12% | 240 |
|
|
2014
Q2 | – | Sell |
-800
| Closed | -$99K | – | 539 |
|
|
2014
Q1 | $99K | Hold |
800
| – | – | 0.03% | 378 |
|
|
2013
Q4 | $91K | Hold |
800
| – | – | 0.03% | 389 |
|
|
2013
Q3 | $90K | Sell |
800
-2,770
| -78% | -$300K | 0.03% | 360 |
|
|
2013
Q2 | $352K | Buy |
+3,570
| New | +$370K | 0.12% | 127 |
|
Other funds holding AMGN
Hillsdale Investment Management's AMGN Position: Q3 2025 in Review
Hillsdale Investment Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 6,490 shares — an estimated $1.81M sold.
Hillsdale Investment Management first reported a position in AMGN in Q2 2013 and held it in 39 quarters. The position peaked at $1.81M in Q2 2025. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Hillsdale Investment Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Hillsdale Investment Management sold 6,490 Amgen shares in Q3 2025, an estimated $1.81M.
- Hillsdale Investment Management first reported a position in Amgen in Q2 2013 and held it in 39 quarters.
- Hillsdale Investment Management's Amgen position peaked at $1.81M in Q2 2025.
- 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.